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LymphedemaAbstract In order to eliminate Lymphatic Filariasis (LF) as a public health problem,
the World Health Assembly recommends an approach which includes interruption of
transmission of infection and the alleviation of morbidity. In 2000, the Togolese
National Program to Eliminate Lymphatic Filariasis (PNELF) started the annual mass
drug administrations and in 2007, the program added a morbidity component for the
management of lymphedema. This manuscript describes the methods of an evalua-
tion aimed at assessing the strengths and weaknesses of the Togolese National
Lymphedema Morbidity Program. The evaluation was conducted through in-depth
interviews with stakeholders at each programmatic level. Interviews focused on
message dissemination, health provider training, patient self-care practices, social
dynamics, and program impact. The evaluation demonstrated that the program
strengths include the standardization and in-depth training of health staff, dissem-
ination of the programs treatment message, a positive change in the communitys
perception of lymphedema, and successful patient recruitment and training in care
techniques. The lessons learned from this evaluation helped to improve Togos pro-
gram, but may also provide guidance and strategies for other countries desiring to
develop a morbidity program. The methods of program evaluation described in this
paper can serve as a model for monitoring components of other decentralized
national health programs in low resource settings.
ª 2014 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
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The global disease burden created by infection
with Lymphatic Filariasis (LF) is profound. Among
the 72 countries (one-fifth) of the worlds popula-
tion at risk for LF, an estimated 44 million people
are symptomatic with lymphedema and/or hydrocele
[1–4]. These chronic maladies also render patients
susceptible to acute infectious attacks. This
morbidity leads to the loss of 5.5 million disability-
adjusted life years (DALYs), thus implicating LF and
its manifestations as the second leading cause of
disability worldwide [5,6]. The impact of disease
is also significant as it carries a social stigma and
psychological morbidity [7].
Although the international efforts to interrupt
transmission have been successful [8], there still
remains a lack of morbidity management programs
targeting the second pillar of the Global Pro-
gramme to Eliminate Lymphatic Filariasis. The pro-
grams that do exist are often very specialized and
geographically focal. This presents both logistical
and financial challenges when bringing these
approaches to a national or even regional scale
[9–12]. Therefore, the morbidity component of the
Togolese National Program to Eliminate Lymphatic
Filariasis (PNELF) is unique in that it is the first
nationally scaled lymphedema management pro-
gram in Africa, even including non-LF endemic
areas. For this reason, a final evaluation of the pro-
gram was of critical importance. This evaluation
would not only strengthen this pilot project, but
would also identify areas to improve the concept
before applying it in other endemic countries. In
summary, this manuscript describes: (1) recom-
mendations for implementing and evaluating a na-
tional lymphedema morbidity program; and (2) an
evaluation method that could be used to evaluate
other decentralized public health programs in low
resource settings.
2. Methods
Togo is a West African country with a population
of approximately 6 million, divided into six re-
gions and 35 districts; 35% of the population lives
below the poverty line. This is a fact of special
importance given the overlap between areas of
poverty and LF endemicity. According to LF map-
ping conducted in 2000, 7 of the countrys 35 dis-
tricts in 3 of its regions were endemic for LF
[13]. The morbidity program, as described by
Mathieu et al. [14], began in 2005 when Togos
Ministry of Health collaborated with the CDC
and through funding by IMA/USAID developed anovel approach to implement a national lymphe-
dema morbidity program.
2.1. Description of the program
The main components of the program were: (1)
train one member of the health staff personnel in
lymphedema care at each dispensary in the 35
national health districts, with a ‘‘training of
trainers’’ approach, including the national LF
coordination team, the district health staff, dis-
pensary nurses, and finally village volunteers; (2)
inform people with a swollen leg that care is avail-
able at the local dispensary, through health educa-
tion, information spread by the administrative
system (prefect, village chief, and town crier),
and media (posters, radio, newspaper, and televi-
sion); (3) diagnose and train patients on how to
care for a swollen leg. This was carried out by
the trained dispensary nurse, using standard care
techniques recommended by the World Health
Organization (WHO) [15]. The soap and towels used
in the training were provided free to the patient as
a one-time donation ‘‘hygiene pack’’ with the aim
of helping patients initiate treatment; (4) provide a
support system to motivate the patients. This was
executed through a combination of family member
support, follow-up visits from a trained village vol-
unteer, and return visits to the dispensary. Clinical
data at these visits were documented in a lymphe-
dema-specific patient booklet, the same style that
is commonly used in the Togo healthcare system
for regular consultations; and (5) integrate lymph-
edema management into the national curriculum
for medical doctors, medical assistants and nurses.
The program was organized slightly differently
in LF endemic and non-endemic health districts.
The most significant difference was that in non-en-
demic areas, patient follow-up was the role of a
family member and not with village volunteers.
Thus, village volunteers in non-endemic districts
did not receive the formal training given to volun-
teers in endemic districts.
2.2. Selection of interview areas
The evaluation encompassed the whole country,
but included oversampling in the 3 regions with
the 7 previously endemic LF districts. A total of 8
districts were sampled. In order to attempt a com-
prehensive and balanced program evaluation, and
to view healthcare units that functioned differ-
ently, the sampling included endemic and non-en-
demic districts and dispensaries that had both
‘‘high’’ and ‘‘low’’ patient enrollment. Within
the region containing three LF endemic districts
Final program evaluation methods and results of a National Lymphedema Management 127(LF districts), the LF districts with the lowest and
highest number of enrolled lymphedema patients
were surveyed, in addition to a randomly selected
non-LF district. In the 2 endemic regions which
had only 2 endemic districts (both with comparable
patient numbers), 1 district was chosen at random.
In the 3 regions without LF districts, 1 district was
randomly selected (Fig. 1).
In each district, two dispensaries were selected:
the dispensary with the highest number of enrolled
patients and one dispensary that had ‘‘low’’
patient numbers reported. The ‘‘low’’ dispensary
was chosen randomly from among the five dispen-
saries with the lowest enrollment. If there were
no patient enrollment data available for a district
or if all dispensaries reported fewer than five en-
rolled patients, two dispensaries were chosen at
random. A list or map of the dispensarys catch-
ment area was used to select a random village.
From there, a minimum of three to five geographi-
cally adjacent villages were visited in each dispen-
sarys catchment area.
2.3. Selection of participants
In-depth interviews were conducted with each of
the five major stakeholders in the program: all(a)
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Figure 1 Map of Togo: (a) by sampled districts; and (b)
evaluation, Togo, 2010.persons with a swollen leg and their family mem-
bers; village volunteers; dispensary nurses; and dis-
trict staff (either LF focal person or district
doctor). In addition, as many village surveys with
community members were performed as time
would allow.
2.4. Interviews
The evaluation team consisted of an interviewer,
transcriber, and translator. The translator was
trained in-depth by the CDC team on the goal of
each question. The translator spoke fluently in
French and Moba (one of the 35 Togolese lan-
guages). This meant that in some villages, inter-
views required translation from English to French
to a local language, facilitated by the translator in
conjunction with a local village volunteer. During
an interview, each member of the team was intro-
duced, and the basic goals of the program evalua-
tion were explained. Next, a series of questions
were asked using pre-developed interview guides,
each one unique for the group of stakeholders being
interviewed. The guides were aimed at addressing
five areas of importance: message dissemination,
provider training, patient self-care practices, social
dynamics, and program impact. The interview(b)
1
by location of dispensaries and villages in the program
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guide was used to make sure that all the desired
questions were addressed. During the interviews,
data were collected on a pre-designed data entry
form for quick answer recording. The team spent
two days in each health district and then feedback
was given to each dispensary nurse and/or the dis-
trict doctor or LF focal point before moving to the
next district.
2.5. Data analyses
After each days work, the transcribed interview
notes were entered into a Microsoft Excel database
taking counts of number of times certain topics were
mentioned in each interview and organizing key
quotes by subject matter. The data were primarily
analyzed qualitatively, drawing out centralized
themes. Community surveys were graded on
percentage of a group responding affirmatively: if
everyone in a community group surveyed knew the
program message, the survey received a 100%
‘‘score’’; 75% for more than half; 50% for exactly
half; 25% for less than half; and 0% if no one was
aware of the message. After recording data in this
way, community surveys could be averaged together
for a given village or district.
3. Ethical considerations
The study protocol was examined by the CDC and
was deemed a program evaluation activity not
involving human subjects research. The protocol
was also submitted to the Ministry of Health in
Togo for approval. Verbal consent was obtained be-
fore all interviews using the local language and
only after providing appropriate details about the
information being collected and its future use.
4. Results
The evaluation included visits to 22 dispensaries and
over 70 villages in 11 health districts in 6 regions of
Togo (Fig. 1). Interviews were conducted with 11
district staff, 20 dispensary nurses, 43 village volun-
teers, 90 patients, 4 family members of patients,
and 87 community surveys. In total, more than 255
participants were involved. Generally, patient
interviews took approximately 20 min, village
volunteer interviews 20–30 min, and dispensary
nurse and district health staff interviews 35–45 min.
4.1. Coverage of the program
With respect to patient recruitment and enroll-
ment, 79% (71/90) of the patients identified duringthe evaluation to have a swollen leg had been seen
at the dispensary for care. Of those 71 patients, 56
(79%) were enrolled in the program. This same
recruitment and enrollment data can be analyzed
based upon endemic and non-endemic districts
and are presented in Table 1. Of the 19 patients
not seen at the dispensary, the majority (13/19)
stated it was because they were not aware of the
treatment message. A closer look at these 13 cases
revealed that in 9 cases the persons community
was also unaware of the message; in 3 other cases,
the community was aware of the message, but did
not inform the patient because they thought the
swollen leg was not severe enough to necessitate
treatment or qualify for enrollment in the pro-
gram; and in the last case, the volunteer was aware
of the treatment message, but had not informed
the patient because he was also a traditional healer
and one of his fellow traditional healer colleagues
was providing treatment for the patient.
Of the 19 patients not seen at the dispensary,
the minority (6/19) were in fact aware of the treat-
ment program: 3 reported lack of means (money or
transportation); 1 reported having been seen at the
dispensary before 2005 and was not aware that this
treatment program was different; 1 thought that
the treatment would not be worthwhile; and the
last 1 did not come as a result of shame related
to his disease.
Among the 15 patients that were seen at a dis-
pensary but not subsequently enrolled were several
patients in non-endemic districts who were re-
ferred to an upper level hospital, but did not have
the transportation means to follow-up. The dispen-
sary nurse in one of these areas described that he
had no other enrolled patients and did not feel
comfortable managing this (stage 5 lymphedema)
patients care. Another common reason patients
were not enrolled in the program was because they
had only episodic swelling, which was not recog-
nized as part of the clinical spectrum of
lymphedema.
4.2. Training
Each level of the health system consistently re-
ported the training being one of the major
strengths of the program. The training sessions
were considered to be clear, efficient, and very de-
tailed. This allowed the trainees to ‘‘feel comfort-
able’’ becoming teachers themselves. The fact
that the training was standardized, and all health
staff in the country were provided with the same
care instructions, was also considered valuable.
Besides using the program manual for the training
sessions, another incredibly worthwhile learning
Table 1 Recruitment and enrollment data for patients with a swollen leg, evaluation of the National Lymphedema
Morbidity Management Program, Togo, 2010.
Total patients No. of patients seen at
dispensary (% total)
No. of patients enrolled
(% total seen at dispensary)
Endemic 57 49 (86%) 45 (92%)
Non-endemic 33 22 (67%) 11 (50%)
Total 90 71 (79%) 56 (79%)
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the training. This aided not only in demonstration
and practice, but also made it possible for the
trainees to hear about what having the disease
meant as a patient. Additionally, having the live
practice at the end of the training session was a
time during which trainees with more experience
in caring for the disease could share thoughts with
those that were less experienced. One dispensary
nurse mentioned:
‘‘At my training, they did demonstrations with a real
patient and then live practice on that patient, which
I thought was effective for learning. . .[an]other
strength was that the trainer was very well informed
and explained everything well, especially disease
[pathology]. . .[an]other strength was that there was
ample time for questions at the end. [Having] more
patients to be able to do live practice on would have
been good.’’
Of note, several trainers also decided to use a
self-created PowerPoint slideshow or video. These
are elements which were not an official part of the
program, but were used to facilitate the learning
process.
Dispensary nurses and patients were interviewed
regarding the care techniques taught to the
patients at the dispensary. When nurses were
questioned about which care techniques were taught,
95% of nurses stated that they taught patients
how to wash the leg, 95% taught about elevation,Table 2 Training of enrolled patients in programs care tech
Management Program, Togo, 2010.a
All patients Washing
Elevation
Exercise
Patients from endemic districts Washing
Elevation
Exercise
Patients from non-endemic districts Washing
Elevation
Exercise
a Patient reported initially being trained (by patient subset).and 91% reported that they taught patients exer-
cises. Among patients surveyed, 100% of enrolled
patients reported being taught washing tech-
niques, 76% elevation, and 79% exercises. Data
were relatively consistent whether the patient
came from an endemic or non-endemic district
(Table 2). For 33% of the patients in non-LF ende-
mic districts, a family member was trained as was
recommended by the program. In endemic dis-
tricts, where training family member was not offi-
cially part of the program, 13% still were. During
follow-up in endemic areas, the vast majority of
village volunteers reported re-teaching patients
the lymphedema management techniques (93%
[25/27], 78% [21/27], and 78% [21/27] for washing,
elevation, and exercise, respectively). Village vol-
unteers were less convinced that the patients were
actually able to follow the care techniques (81%
[22/27], 64% [16/25], and 64% [16/25], respec-
tively), and 100% of the patients in the program re-
ported being able to wash initially, but performing
the elevation and exercise was considered more
difficult (71% and 74% adherence, respectively).
At the time of interviews during this evaluation,
which for most patients was between one and
three years after the initial training, 80% (45/56)
of patients stated that they were still doing their
washing and 61% (33/54) of the patients stated that
they were performing elevation and exercises
(Table 3). A factor that influenced adherence wasniques, evaluation of the National Lymphedema Morbidity
Total N n Percent (%)
56 56 100
54 41 76
56 44 79
47 47 100
46 35 76
47 37 79
11 11 100
11 8 73
11 8 73
130 J. Ziperstein et al.having a basic understanding of the disease mech-
anism; when patients were aware that the swollen
leg was due to fluid buildup caused by defective
circulation, they were able to understand the three
treatment tenets.
4.3. Health education
Community surveys on message dissemination
showed that there was 62% ‘‘coverage’’ rate of
message recall among all villages, when averaged
as described above. In general, within a given
village or set of villages, either everyone knew
the message or no one knew the message. Message
dissemination was accomplished through the methods
that were officially part of the training program
and also through avenues created by the dispensary
nurse, such as having an announcement made by
teachers at school or an informal meeting at the
site of a farming collective. District level healthTable 4 Optimal methods of message dissemination report
Lymphedema Morbidity Management Program, Togo, 2010.
Stakeholder/responder Best message dissem
District supervisors (N = 12) Village volunteers
Mass media
Town crier
Dispensary
Dispensary nurses (N = 21) Village volunteers
Dispensary
Town crier
Lymphedema patients (N = 41) Village volunteers
Dispensary
Family member
Town crier
Mass media
Private doctor
Table 3 Village volunteer and patient reported adherence
Lymphedema Morbidity Management Program, Togo, 2010.
Patien
Total
All patients Washing 56
Elevation 54
Exercise 56
Patients from endemic districts Washing 47
Elevation 47
Exercise 47
Patients from non-endemic districts Washing 11
Elevation 11
Exercise 11staffers that worked in rural areas were more likely
to endorse village volunteers as the best method,
while those in urban locales more often supported
mass media. Sixty-seven percent of patients with a
swollen leg (regardless of enrollment status) said
that they were aware of the program message.
Patients with a swollen leg heard the message
mainly from village volunteers and from the
dispensary (Table 4). The most effective method
to encourage patients to seek care was an active,
trained village volunteer.
When radio was used, health staff noted that
having the broadcast occur multiple times in sev-
eral of the different local languages was important.
Spreading the treatment message during mass drug
administration (MDA) was also effective and re-
sulted in the population having a more complete
understanding of the link between LF, lymphedema,
hydrocele, and MDA. This helped to reinforce the
concept of lymphedema as a sequela of a treatableed by program stakeholders, evaluation of the National
ination method Number of positive responses
5
4
2
1
14
4
3
16
11
5
4
4
1
to care techniques over time, evaluation of the National
t able to do initially Patient able to do it after
3 years
N n Percent (%) Total N n Percent (%)
56 100 56 45 80
38 70 54 33 61
41 73 56 36 64
47 100 47 41 87
33 70 47 29 62
34 72 47 33 70
11 100 11 6 54
9 82 10 6 60
9 82 11 5 45
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or curse. One district-level official noted that:
‘‘Originally, LF was thought to be a spiritual disease,
so at first they tried to cure it with traditional medi-
cine; but there is no cure. So if we increase sensitiza-
tion, even a small farmer will know the cause, and it
will be a success.’’
Forty percent of district supervisors reported a
change in community perception regarding LF after
dissemination of the message; this opinion was
shared among 67% (14/21) of dispensary nurses
and 91% (39/43) of village volunteers. Regarding
message dissemination, one village volunteer said:
‘‘Before the message dissemination, there was a lot
of discrimination, but now its just like HIV – its just
another disease.’’4.4. Follow up
Of patients living in endemic villages, 82% (47/57)
were visited at home by a village volunteer and
more than half reported help from a family mem-
ber at home. In LF non-endemic districts,
although follow-up from a village volunteer was
not an official part of the program, 67% (22/33)
of patients were still provided follow-up by a vil-
lage volunteer. Overall, the patients that had the
most consistent follow-up were those that were
followed both by a village volunteer and a family
member. One dispensary nurse said:
‘‘The best setup would be [to train] both, a synergy
between family, ASC [village volunteer] and patient
for follow-up.’’
Patients thought that the booklets filled out at
follow-up visits were helpful for several reasons.
First, the drawings on the front and back inside
cover helped remind them of the care techniques.
Second, patients appreciated being able to read
the notes and see improvement in clinical status.
Third, patients said that a filled-in booklet was a
tangible piece of evidence that someone was visit-
ing them and cared about their health, a fact even
appreciated by several illiterate patients. One pa-
tient noted:
‘‘I can see the booklet and be reminded of what I have
done [by looking at the pictures] and realize that I am
not alone. When someone follows up (in the booklet),
it is encouraging.’’
Although 59% (16/27) of village volunteers re-
ported that patients had difficulty in obtaining sup-
plies, only 49% (13/27) of patients confirmed this
fact. The most common problem was finding soap,
but two patients mentioned having difficulty withobtaining clean water and dry towels. When speak-
ing about material availability, one village volun-
teer said:
‘‘. . .In the early years, the patients were given soap
and towels; these materials have run out and now
the patients feel abandoned.’’5. Discussion
The Togolese national program to eliminate lym-
phatic filariasis (PNELF) introduced a novel nation-
wide approach to alleviate lymphedema morbidity
associated with LF. Three years after the program
was launched, it was determined that a program
evaluation would provide critical information
regarding the successes and lessons learned from
this pilot project so that similar programs might
be introduced elsewhere. A sampling method was
elaborated which took important confounding fac-
tors into account, such as LF endemicity, high prev-
alence of patients and/or motivated health staff.
The idea behind this methodology was that it could
be easily adapted for similar public health pro-
grams. The key areas which were addressed
through interviews of stakeholders at all levels of
the program included: message dissemination, pro-
vider training, patient self-care, social dynamics,
and program impact.
The dissemination of the health education mes-
sage has a two-pronged objective: to identify pa-
tients and to educate the general population
about the existence of LF as an infectious disease.
The subsequent method of recruitment which was
most likely to bring patients into the program was
the use of well-informed village volunteers. A
likely reason for this is that many patients with
lymphedema have been struggling with the disease
for many years and have tried various treatments
[7]. When an actual person visited their home and
explained the concept of lymphedema treatment
as new, prophylactic, and cost-effective, patients
were much more likely to visit the dispensary. It
seemed that more passive methods, such as mass
media, town crier, and posters, were not as
effective.
Seventy-nine percent of patients seen at the dis-
pensary were enrolled – a high value for a public
health program, especially considering the
stigmatizing nature of the disease and the limited
knowledge regarding disease etiology. The majority
of people suffering from lymphedema that did hear
the message went to the dispensary to seek help.
Village volunteers seemed incredibly effective at
recruiting patients, but when a village volunteer
had not been formally trained and lacked detailed
132 J. Ziperstein et al.information regarding the treatment, as was the
case in non-endemic districts, he/she could not
make a convincing case for the treatment program.
The patients that had the most consistent
follow-up were those that were followed by both
a village volunteer and a family member. This
setup allowed for a system where initially frequent
village volunteer visits transitioned to family mem-
ber-based care over time. The next best method
was to use only a trained village volunteer, which
was superior to having only a family member.
Although village volunteers were not paid, they
considered visiting the patients their ‘‘job’’, while
family members often helped only if they had extra
time.
When patients had a good understanding of the
treatment goals, expectations could be met and
adherence was improved. Patients sometimes had
a difficult time understanding that the treatment
did not include medications. One dispensary nurse
described that ‘‘In Africa, people think that treat-
ment is a medicine; when you dont give someone
medicine, they dont think it is a treatment.’’
Throughout patient and health staff interviews,
village volunteers were identified as the major fea-
ture that allowed the program to function and
make morbidity management accessible. In the
current program, village volunteers are only offi-
cially utilized in the endemic districts, where there
are existing LF volunteers. The use of village volun-
teers who are also involved in other health pro-
grams is an innovative piece of the program, and
it is recommended to expand their inclusion in all
districts, also the non-LF endemic district. Given
cost and time constraints, the training need not
be as in-depth of a session, but would at least in-
clude the basic mechanisms of disease, simple con-
cepts of treatment, and most importantly that the
treatment is inexpensive, effective, and easy to
perform. With this information, the village volun-
teers could effectively function in the roles of mes-
sage disseminators, case finders and patient
recruiters. When and if a village volunteer did lo-
cate a case, he/she could accompany the patient
to the dispensary and receive full training in the
care techniques along with the patient. This would
allow him/her to perform follow-up.
The above points on the village volunteers role
in the program are one explanation for why the
program generally functioned more effectively in
endemic areas. Another possible explanation is
the increased community awareness of lymphe-
dema in populations familiar with MDA campaigns
for LF. Lastly, it is possible that the dispensary
nurses in endemic districts were more proficientat managing the program, possibly due to the fact
that endemic areas typically had more practice in
managing cases.
The authors observe that a potential limitation
of the current study includes the use of non-proba-
bility sampling design for the selection of villages
in each dispensarys catchment area. This qualita-
tive evaluation relied on in-depth interviews
requiring strategic methods to be put in place to
minimize the potential introduction of interviewer
and response biases. Interviewer training and data
recording methods were standardized among all
interviewers to ensure that objective recording
procedures were used.
Language translation and back translation mea-
sures were completed with care since it was neces-
sary that interviews be conducted in the local
language, that responses be back translated into
French, and that final results be reported in Eng-
lish. The authors note that collecting data in one
language and presenting the findings in another
can involve many factors that may influence the
quality of translation which in turn may have a di-
rect impact on the validity of the research.
Despite these potential limitations, this study
tested a program evaluation method that can help
guide programmers to evaluate similar national
programs in a way that uses few resources, is easy
to implement, is replicable, and is able to procure
data with wide geographic coverage from all dis-
tricts of interest. The authors anticipate that the
description of such an evaluation will demonstrate
the important role evaluation has in national pro-
gram implementation and will encourage further
use of such evaluations in non-academic settings.
Furthermore, the method in which this evaluation
was carried out has allowed for important indicators
of program quality and adherence to be measured,
and encourages the free flow of opinions at all
levels of the program structure. The qualitative
data have illustrated the strengths and weaknesses
of such a program and provide great utility in
program monitoring and evaluation.
In conclusion, this complete program evaluation
was critical for three reasons. First, the program
continues to function in Togo, and lessons learned
can help to determine program organization, fund-
ing, and delivery in the future. Secondly, there is a
deficiency of morbidity programs in nearby LF-en-
demic countries, several of which are considering
the feasibility of initiating national morbidity pro-
grams. Being able to understand the strengths
and weaknesses of the Togolese national program
is invaluable to these health systems. Lastly, the
unique method of evaluation described here can
Final program evaluation methods and results of a National Lymphedema Management 133help to monitor the effectiveness of these future
programs and other public health programs.Disclaimer
The findings and conclusions in this report are the
findings and conclusions of the authors and do not
necessarily represent the views of the Centers for
Disease Control and Prevention.References
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